Cargando…

Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Following an application from Unilever NV, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scienti...

Descripción completa

Detalles Bibliográficos
Autores principales: Turck, Dominique, Bresson, Jean‐Louis, Burlingame, Barbara, Dean, Tara, Fairweather‐Tait, Susan, Heinonen, Marina, Hirsch‐Ernst, Karen Ildico, Mangelsdorf, Inge, McArdle, Harry J, Naska, Androniki, Neuhäuser‐Berthold, Monika, Nowicka, Grażyna, Pentieva, Kristina, Sanz, Yolanda, Sjödin, Anders, Stern, Martin, Tomé, Daniel, Van Loveren, Henk, Vinceti, Marco, Willatts, Peter, Martin, Ambroise, Strain, Sean (JJ), Siani, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009616/
https://www.ncbi.nlm.nih.gov/pubmed/32625903
http://dx.doi.org/10.2903/j.efsa.2018.5266
_version_ 1783495706530545664
author Turck, Dominique
Bresson, Jean‐Louis
Burlingame, Barbara
Dean, Tara
Fairweather‐Tait, Susan
Heinonen, Marina
Hirsch‐Ernst, Karen Ildico
Mangelsdorf, Inge
McArdle, Harry J
Naska, Androniki
Neuhäuser‐Berthold, Monika
Nowicka, Grażyna
Pentieva, Kristina
Sanz, Yolanda
Sjödin, Anders
Stern, Martin
Tomé, Daniel
Van Loveren, Henk
Vinceti, Marco
Willatts, Peter
Martin, Ambroise
Strain, Sean (JJ)
Siani, Alfonso
author_facet Turck, Dominique
Bresson, Jean‐Louis
Burlingame, Barbara
Dean, Tara
Fairweather‐Tait, Susan
Heinonen, Marina
Hirsch‐Ernst, Karen Ildico
Mangelsdorf, Inge
McArdle, Harry J
Naska, Androniki
Neuhäuser‐Berthold, Monika
Nowicka, Grażyna
Pentieva, Kristina
Sanz, Yolanda
Sjödin, Anders
Stern, Martin
Tomé, Daniel
Van Loveren, Henk
Vinceti, Marco
Willatts, Peter
Martin, Ambroise
Strain, Sean (JJ)
Siani, Alfonso
collection PubMed
description Following an application from Unilever NV, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to black tea and improvement of attention. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is black tea. The Panel considers that black tea characterised by its content of tea solids, caffeine and l‐theanine, which is the subject of the health claim, is sufficiently characterised in relation to the claimed effect. The claimed effect proposed by the applicant is ‘improves attention’. The Panel considers that improvement of attention is a beneficial physiological effect. Three human intervention studies provided by the applicant show an effect of black tea on attention under the conditions of used proposed by the applicant. The applicant proposed that the claimed effect depends on the concerted action of two substances, caffeine and l‐theanine, both of which are present in black tea. The Panel considers that the effect of black tea on attention observed in the three human intervention studies provided by the applicant can be explained by its caffeine content. The Panel concludes that a cause and effect relationship has been established between the consumption of black tea and improvement of attention. The Panel considers that the effect of black tea on attention can be explained by its caffeine content. The following wording reflects the scientific evidence: ‘Owing to its caffeine content, black tea improves attention’. In order to obtain the claimed effect, 2–3 servings of black tea providing at least 75 mg of caffeine in total should be consumed within 90 min.
format Online
Article
Text
id pubmed-7009616
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70096162020-07-02 Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 Turck, Dominique Bresson, Jean‐Louis Burlingame, Barbara Dean, Tara Fairweather‐Tait, Susan Heinonen, Marina Hirsch‐Ernst, Karen Ildico Mangelsdorf, Inge McArdle, Harry J Naska, Androniki Neuhäuser‐Berthold, Monika Nowicka, Grażyna Pentieva, Kristina Sanz, Yolanda Sjödin, Anders Stern, Martin Tomé, Daniel Van Loveren, Henk Vinceti, Marco Willatts, Peter Martin, Ambroise Strain, Sean (JJ) Siani, Alfonso EFSA J Scientific Opinion Following an application from Unilever NV, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to black tea and improvement of attention. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is black tea. The Panel considers that black tea characterised by its content of tea solids, caffeine and l‐theanine, which is the subject of the health claim, is sufficiently characterised in relation to the claimed effect. The claimed effect proposed by the applicant is ‘improves attention’. The Panel considers that improvement of attention is a beneficial physiological effect. Three human intervention studies provided by the applicant show an effect of black tea on attention under the conditions of used proposed by the applicant. The applicant proposed that the claimed effect depends on the concerted action of two substances, caffeine and l‐theanine, both of which are present in black tea. The Panel considers that the effect of black tea on attention observed in the three human intervention studies provided by the applicant can be explained by its caffeine content. The Panel concludes that a cause and effect relationship has been established between the consumption of black tea and improvement of attention. The Panel considers that the effect of black tea on attention can be explained by its caffeine content. The following wording reflects the scientific evidence: ‘Owing to its caffeine content, black tea improves attention’. In order to obtain the claimed effect, 2–3 servings of black tea providing at least 75 mg of caffeine in total should be consumed within 90 min. John Wiley and Sons Inc. 2018-05-24 /pmc/articles/PMC7009616/ /pubmed/32625903 http://dx.doi.org/10.2903/j.efsa.2018.5266 Text en © 2018 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. https://creativecommons.org/licenses/by-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ (https://creativecommons.org/licenses/by-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made.
spellingShingle Scientific Opinion
Turck, Dominique
Bresson, Jean‐Louis
Burlingame, Barbara
Dean, Tara
Fairweather‐Tait, Susan
Heinonen, Marina
Hirsch‐Ernst, Karen Ildico
Mangelsdorf, Inge
McArdle, Harry J
Naska, Androniki
Neuhäuser‐Berthold, Monika
Nowicka, Grażyna
Pentieva, Kristina
Sanz, Yolanda
Sjödin, Anders
Stern, Martin
Tomé, Daniel
Van Loveren, Henk
Vinceti, Marco
Willatts, Peter
Martin, Ambroise
Strain, Sean (JJ)
Siani, Alfonso
Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_full Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_fullStr Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_full_unstemmed Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_short Black tea and improvement of attention: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
title_sort black tea and improvement of attention: evaluation of a health claim pursuant to article 13(5) of regulation (ec) no 1924/2006
topic Scientific Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009616/
https://www.ncbi.nlm.nih.gov/pubmed/32625903
http://dx.doi.org/10.2903/j.efsa.2018.5266
work_keys_str_mv AT blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT turckdominique blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT bressonjeanlouis blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT burlingamebarbara blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT deantara blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT fairweathertaitsusan blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT heinonenmarina blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT hirschernstkarenildico blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT mangelsdorfinge blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT mcardleharryj blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT naskaandroniki blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT neuhauserbertholdmonika blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT nowickagrazyna blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT pentievakristina blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT sanzyolanda blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT sjodinanders blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT sternmartin blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT tomedaniel blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT vanloverenhenk blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT vincetimarco blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT willattspeter blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT martinambroise blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT strainseanjj blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006
AT sianialfonso blackteaandimprovementofattentionevaluationofahealthclaimpursuanttoarticle135ofregulationecno19242006